Department of Microbiology and Immunology, Rush University Medical Center, Chicago, Illinois 60612, United States.
Biochemistry. 2011 Jul 5;50(26):5870-82. doi: 10.1021/bi200107n. Epub 2011 Jun 10.
Thioredoxin glutathione reductase from Schistosoma mansoni (SmTGR) catalyzes the reduction of both thioredoxin and glutathione disulfides (GSSG), thus playing a crucial role in maintaining redox homeostasis in the parasite. In line with this role, previous studies have demonstrated that SmTGR is a promising drug target for schistosomiasis. To aid in the development of efficacious drugs that target SmTGR, it is essential to understand the catalytic mechanism of SmTGR. SmTGR is a dimeric flavoprotein in the glutathione reductase family and has a head-to-tail arrangement of its monomers; each subunit has the components of both a thioredoxin reductase (TrxR) domain and a glutaredoxin (Grx) domain. However, the active site of the TrxR domain is composed of residues from both subunits: FAD and a redox-active Cys-154/Cys-159 pair from one subunit and a redox-active Cys-596'/Sec-597' pair from the other; the active site of the Grx domain contains a redox-active Cys-28/Cys-31 pair. Via its Cys-28/Cys-31 dithiol and/or its Cys-596'/Sec-597' thiol-selenolate, SmTGR can catalyze the reduction of a variety of substrates by NADPH. It is presumed that SmTGR catalyzes deglutathionylation reactions via the Cys-28/Cys-31 dithiol. Our anaerobic titration data suggest that reducing equivalents from NADPH can indeed reach the Cys-28/Cys-31 disulfide in the Grx domain to facilitate reductions effected by this cysteine pair. To clarify the specific chemical roles of each redox-active residue with respect to its various reactivities, we generated variants of SmTGR. Cys-28 variants had no Grx deglutathionylation activity, whereas Cys-31 variants retained partial Grx deglutathionylation activity, indicating that the Cys-28 thiolate is the nucleophile initiating deglutathionylation. Lags in the steady-state kinetics, found when wild-type SmTGR was incubated at high concentrations of GSSG, were not present in Grx variants, indicating that this cysteine pair is in some way responsible for the lags. A Sec-597 variant was still able to reduce a variety of substrates, albeit slowly, showing that selenocysteine is important but is not the sole determinant for the broad substrate tolerance of the enzyme. Our data show that Cys-520 and Cys-574 are not likely to be involved in the catalytic mechanism.
曼氏血吸虫硫氧还蛋白-谷胱甘肽还原酶(SmTGR)可催化硫氧还蛋白和谷胱甘肽二硫化物(GSSG)的还原,因此在寄生虫的氧化还原稳态维持中发挥关键作用。与这一作用一致,先前的研究表明 SmTGR 是血吸虫病的一个很有前途的药物靶点。为了开发针对 SmTGR 的有效药物,了解 SmTGR 的催化机制至关重要。SmTGR 是谷胱甘肽还原酶家族中的二聚体黄素蛋白,其单体呈头尾排列;每个亚基都具有硫氧还蛋白还原酶(TrxR)结构域和谷氧还蛋白(Grx)结构域的组成部分。然而,TrxR 结构域的活性位点由两个亚基的残基组成:一个亚基的 FAD 和一个氧化还原活性的 Cys-154/Cys-159 对,另一个亚基的氧化还原活性 Cys-596'/Sec-597' 对;Grx 结构域的活性位点包含一个氧化还原活性的 Cys-28/Cys-31 对。通过其 Cys-28/Cys-31 二硫键和/或 Cys-596'/Sec-597' 硫醇-硒醇,SmTGR 可以催化 NADPH 还原多种底物。据推测,SmTGR 通过 Cys-28/Cys-31 二硫键催化脱谷胱甘肽化反应。我们的厌氧滴定数据表明,NADPH 的还原当量确实可以到达 Grx 结构域中的 Cys-28/Cys-31 二硫键,以促进该半胱氨酸对的还原。为了阐明每个氧化还原活性残基对其各种反应性的具体化学作用,我们生成了 SmTGR 的变体。Cys-28 变体没有 Grx 脱谷胱甘肽化活性,而 Cys-31 变体保留了部分 Grx 脱谷胱甘肽化活性,表明 Cys-28 硫醇是引发脱谷胱甘肽化的亲核试剂。当野生型 SmTGR 在高浓度 GSSG 下孵育时,在稳态动力学中发现的滞后现象在 Grx 变体中不存在,这表明该半胱氨酸对在某种程度上负责滞后现象。Sec-597 变体仍然能够缓慢地还原多种底物,表明硒代半胱氨酸很重要,但不是酶对广泛底物耐受性的唯一决定因素。我们的数据表明 Cys-520 和 Cys-574 不太可能参与催化机制。